Evidence map›Paper›PMID 29481017›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2018

Antimigration Activity of an Ethylacetate Fraction of Zanthoxylum acanthopodium DC. Fruits in 4T1 Breast Cancer Cells

Urip Harahap, Poppy Anjelisa Zaitun Hasibuan, Panal Sitorus, Nur Arfian, Denny Satria

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. The Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Article
  3. The ethyl acetate extract ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  4. Andaliman (Heliyon · 2023
    Review
  5. Synergistic Antibacterial Effect of Ethyl Acetate Fraction ofAdvances in pharmacological and pharmaceutical sciences · 2023
    Article
  6. Phytochemical Analysis by FTIR ofMedical archives (Sarajevo, Bosnia and Herzegovina) · 2023
    Article
  7. Frontiers in pharmacology · 2021
    Review
  8. Article
  9. Cell Cycle Inhibition and Apoptotic Induction ofOpen access Macedonian journal of medical sciences · 2019
    Article
  10. Cytotoxic Activity of BornUSU I towards T47D Breast Cancer Cells.Open access Macedonian journal of medical sciences · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Urip HarahapDepartment of Pharmacology, Faculty of Pharmacy, University of Sumatera Utara, Indonesia. Email: uripharahap@usu.ac.id
Poppy Anjelisa Zaitun Hasibuan
Panal Sitorus
Nur Arfian
Denny Satria
University of North Sumatra · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study was carried out to investigate the antimigration activity of Zanthoxylum acanthopodium DC. in the 4T1 breast cancer cell line. Methods: Zanthoxylum acanthopodium DC. fruit powder was extracted by maceration method with n-hexane and ethylacetate solvents. Cytotoxicity and proliferation were assessed using the MTT method and the cell cycle by flow cytometry. In addition, wound healing assays were conducted by a microscopic method, and expression of COX-2 and VEGFR-2 were determined using qRT-PCR. Results: The IC50 of the ethylacetate fraction (EAF) was 48.1 ± 1.06 μg/mL. The EAE at a concentration 10 μg/mL with viable cells was 62.3 ± 0.28% after 72 h incubation, with accumulation in the G2-M phase, inhibition of cell migration in the wound healing assay, and decrease in expression of COX-2 (0.62 ± 0.01) and VEGFR-2 (0.39 ± 0.003). Conclusion: The results reveal that an ethylacetate fraction of Zanthoxylum acanthopodium DC. fruits provides effective antimigration effects. Further studies are now planned to assess the potential of the ethylacetate fraction to inhibit angiogenesis in breast cancer and determine underlying mechanisms.

Indexed as

AnimalsAntineoplastic AgentsBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationCyclooxygenase 2FemaleFruitG2 Phase Cell Cycle CheckpointsMiceNeovascularization, PathologicPlant ExtractsVascular Endothelial Growth Factor Receptor-2Wound HealingZanthoxylumAntineoplastic AgentsCyclooxygenase 2Plant ExtractsVascular Endothelial Growth Factor Receptor-2AntimigrationethylacetateZanthoxylum acanthopodium DC. fruits

Identifiers

PMID29481017
PMCPMC5980951
OpenAlexW2788632391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.